首页>
外国专利>
USE OF A FUSION PROTEIN BETWEEN A CYTOKINE AND AN ANTIBODY TARGETING THE ED-B FIBRONECTIN DOMAIN FOR THE TREATMENT OF ATHEROSCLEROSIS
USE OF A FUSION PROTEIN BETWEEN A CYTOKINE AND AN ANTIBODY TARGETING THE ED-B FIBRONECTIN DOMAIN FOR THE TREATMENT OF ATHEROSCLEROSIS
展开▼
机译:细胞因子和靶向ED-B纤维蛋白原域的抗体之间融合蛋白在治疗动脉粥样硬化中的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to the use of a fusion protein comprising an antibody part which specifically recognises the oncofetal extra domain B (ED-B) of fibronectin, an effector part and optionally one or more fusion protein linker(s) and/or antibody linker(s), for the manufacturing of medicaments for the treatment of atherosclerosis
展开▼